BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Telix Pharmaceuticals and ANMI Partner for Prostate Cancer Imaging

  The agreement includes filing a Drug Master File (DMF) for the Kit, and completion of the necessary clinical trials to obtain marketing authorisation from the FDA.

  October 24, 2017

   · 

  4 min read
• Deals

  Telix Pharmaceuticals Limited Launches $50M Underwritten Initial Public Offering

  The IPO is an offer by Telix for the issue of 77.0 million shares at $0.65 per share and is fully underwritten by the Lead Managers, Taylor Collison Limited and Wilsons Corporate Finance Limited

  October 24, 2017

   · 

  3 min read
• SGX-Listed Singapore eDevelopment Subsidiary Global BioLife Develops Breakthrough Modified Sugar

  SGX-Listed Singapore eDevelopment Ltd (“Sed”) announced today that U.S. biomedical subsidiary Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose.

  October 24, 2017

   · 

  4 min read
• Pharm Country

  Inovio and U.S. Army Co-Developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study

  These results were published in the most recent issue of Human Vaccines & Immunotherapeutics.

  October 24, 2017

   · 

  6 min read
• 

  Business

  LinkSPINE Names Dennis Farrell President and CEO

  Farrell has been with LinkSPINE since 2011, serving as President since 2015.

  October 24, 2017

   · 

  2 min read
• Drug Manufacturers and the New FDA Drug Listing Rules - a Primer From Data Conversion Laboratory

  Data Conversion Laboratory (DCL) is offering a free webinar on October 26 at 1:00pm ET to explain the new FDA drug listing rules, which will be affecting all U.S. drug listings.

  October 24, 2017

   · 

  2 min read
• Drug Development

  Dimerix Receives Ethics Committee Approval in Australia for Pharmacokinetic Trial of New Extended Release Formulation

  Dimerix Limited, is pleased to announce that it has received ethics committee approval for a study in healthy volunteers to determine the pharmacokinetic properties of the novel extended release propagermanium tablet to be used in the Company’s DMX-200 Phase 2b trial in Chronic Kidney Disease.

  October 24, 2017

   · 

  3 min read
• Business

  Dr. Istvan Udvaros Joins Cristal Therapeutics as New Chief Medical Officer

  Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, has appointed Dr. Istvan Udvaros as its Chief Medical Officer (CMO) with immediate effect.

  October 24, 2017

   · 

  2 min read
• Business

  Corindus Vascular Robotics to Report Third Quarter 2017 Financial Results on November 7, 2017

  Corindus Vascular Robotics today announced that it will release financial and business results for the second quarter of 2017 after the close of trading on Tuesday, November 7, 2017.

  October 24, 2017

   · 

  2 min read
• Business

  Titan Medical and Columbia University Medical Center Announce the Successful Installation of Titan’s Sport Surgical System

  TITAN Medical Inc. announce the installation of Titan Medical’s SPORT Surgical System at Columbia’s simulation training facility in New York City.

  October 24, 2017

   · 

  3 min read